Search results
Novavax (NASDAQ:NVAX) PT Raised to $18.00
ETF DAILY NEWS· 18 hours agoNovavax (NASDAQ:NVAX – Get Free Report) had its target price increased by Bank of America from $12.00 to $18.00 in a research report issued to clients and investors on Friday ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoNovavax stock isn't a buy. Savvy investors are encouraged to buy a stock after it breaks out of a...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 2 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 3 days agoBut the good news is that the newly dominant variants don’t appear more likely to cause severe...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 2 days agoThose concerns are now alleviated as Novavax has agreed to refund up to $475 million. More recently, there was news that Novavax entered ...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 1 day agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 1 day agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration (FDA) announced ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 6 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 6 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Abbott Labs Enters The U.S. Obesity Arena
Investor's Business Daily· 6 days agoAbbott Laboratories (ABT) gained U.S. clearance Monday for a pair of new continuous glucose monitors. The Food and Drug Administration signed off on...
